E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 996.2 ILS 1.67%
Market Cap: 294m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note

Epitomee Medical Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epitomee Medical Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
NNOX
B
BWAY
INMD
1696
S
SOFW

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
E
Epitomee Medical Ltd
TASE:EPIT
Cash & Cash Equivalents
$15.6m
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Cash & Cash Equivalents
$56.4m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Cash & Cash Equivalents
$46m
CAGR 3-Years
39%
CAGR 5-Years
39%
CAGR 10-Years
16%
Inmode Ltd
NASDAQ:INMD
Cash & Cash Equivalents
$403.4m
CAGR 3-Years
49%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Cash & Cash Equivalents
$70.2m
CAGR 3-Years
-18%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Cash & Cash Equivalents
$24.4m
CAGR 3-Years
110%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Epitomee Medical Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
15.6m USD

Based on the financial report for Dec 31, 2023, Epitomee Medical Ltd's Cash & Cash Equivalents amounts to 15.6m USD.

What is Epitomee Medical Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
48%

Over the last year, the Cash & Cash Equivalents growth was -57%. The average annual Cash & Cash Equivalents growth rates for Epitomee Medical Ltd have been 48% over the past three years .

Back to Top